| Molecular Cancer | |
| Abbreviation: | Mol. Cancer |
| Discipline: | Biology |
| Editor: | Chi V. Dang |
| Publisher: | Springer Science+Business Media |
| History: | 2002–present |
| Impact: | 41.444 |
| Impact-Year: | 2021 |
| Issn: | 1476-4598 |
| Website: | https://molecular-cancer.biomedcentral.com/ |
| Link2: | https://molecular-cancer.biomedcentral.com/articles |
| Link2-Name: | Online archive |
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research.
The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research.[1] Professor C. Nicot has been editor-in-chief since 2014.
Molecular Cancer publishes research articles, reviews, and commentaries related to cancer biology, molecular oncology, cancer genetics, epigenetics, signal transduction, and targeted therapy.[2]
The journal is indexed in PubMed, and Scopus.[3] The journal has a 2021 impact factor of 41.444, according to the Journal Citation Reports.[4]